Biomarkers.

Background: Amyloid and alpha synuclein proteins are brain biomarkers of different neurodegenerative diseases, many years before symptoms. We have shown that imaging dye-free with polarized light makes retinal amyloid deposits visible as a biomarker, in the brain, of amyloid and Alzheimer's disease (AD) severity. Here, we extend to presumed retinal alpha synuclein deposits in those with brain pathology consistent with alpha synuclein.

Changes in fixation in the presence of prism monitored with a confocal scanning laser ophthalmoscope.

BACKGROUND: The main optical effect of an ophthalmic prism is to deviate uniformly the entire field of view seen through the prism, resulting in an equal eye movement, if fixation on the same object is to be maintained. Conversely, it has been suggested that, in the case of low vision due to central scotoma, the eye changes its eccentric viewing behaviour when a prism is introduced, that is, the eye remains stationary with a change of retinal image location. METHOD: A new method is described in which retinal image position was recorded with a confocal scanning laser ophthalmoscope in four experimental conditions.